Search research articles
Contact Us
Filters
Showing results (61-70 of 98) with videos related to
Page
of 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Cell Reports
|
May 31, 2018
Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
Tatjana Sajic, Yansheng Liu, Eirini Arvaniti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer
Sarah Blagden, Aurelius Omlin, Aurelius Olmin, et al.
Clinical Genitourinary Cancer
|
June 2, 2016
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
David Lorente, Aurelius Omlin, Zafeiris Zafeiriou, et al.
The Lancet. Oncology
|
August 5, 2006
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network
Aurelius Omlin, Maurizio Amichetti, David Azria, et al.
Future Oncology (London, England)
|
February 5, 2014
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer
L Rhoda Molife, Aurelius Omlin, Rob J Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)
Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz, et al.
European Urology
|
October 29, 2024
What's in a Name? Why Words Matter in Advanced Prostate Cancer
William K Oh, Neeraj Agarwal, Alan Bryce, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Julian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
Cancers
|
April 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 98) with videos related to
Sort By:
Page
of 10
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Cell Reports
|
May 31, 2018
Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
Tatjana Sajic, Yansheng Liu, Eirini Arvaniti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer
Sarah Blagden, Aurelius Omlin, Aurelius Olmin, et al.
Clinical Genitourinary Cancer
|
June 2, 2016
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
David Lorente, Aurelius Omlin, Zafeiris Zafeiriou, et al.
The Lancet. Oncology
|
August 5, 2006
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network
Aurelius Omlin, Maurizio Amichetti, David Azria, et al.
Future Oncology (London, England)
|
February 5, 2014
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer
L Rhoda Molife, Aurelius Omlin, Rob J Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)
Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz, et al.
European Urology
|
October 29, 2024
What's in a Name? Why Words Matter in Advanced Prostate Cancer
William K Oh, Neeraj Agarwal, Alan Bryce, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Julian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
Cancers
|
April 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, et al.
Page
of 10